INS and type 1 diabetes mellitus: In an extension of this study, a higher dose of up to 30×106 cells/kg was well tolerated and associated with some clinical improvement after 12 months (reduction in insulin requirement and higher C-peptide levels).122 In a recent study in adults with newly diagnosed type 1 diabetes,50 a dose escalation protocol was used to assess the maximum tolerated dose of Tregs.